Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Retained Earnings (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Retained Earnings data on record, last reported at -$3.1 million in Q4 2025.

  • For Q4 2025, Retained Earnings rose 92.33% year-over-year to -$3.1 million; the TTM value through Dec 2025 reached -$3.1 million, up 92.33%, while the annual FY2025 figure was -$3.1 million, 92.33% up from the prior year.
  • Retained Earnings reached -$3.1 million in Q4 2025 per ORGO's latest filing, up from -$46.8 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$3.1 million in Q4 2025 and bottomed at -$140.8 million in Q1 2021.
  • Average Retained Earnings over 5 years is -$59.4 million, with a median of -$50.8 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: crashed 37.97% in 2024, then skyrocketed 92.33% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$60.8 million in 2021, then grew by 25.53% to -$45.3 million in 2022, then rose by 9.56% to -$41.0 million in 2023, then rose by 2.1% to -$40.1 million in 2024, then surged by 92.33% to -$3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$3.1 million in Q4 2025, -$46.8 million in Q3 2025, and -$68.3 million in Q2 2025.